MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Differential Effect of alpha-Synuclein on Mitochondrial Morphology in PD and MSA

    O. Driskill, E. Ostrakhovitch, J. Patel, J. Stegemann, T. Yamasaki (Lexington, USA)

    Objective: In this study, we investigated the morphology of mitochondria and localization of alpha-synuclein as driven by alpha-synuclein isolated from PD and MSA brain-derived tissue.…
  • 2025 International Congress

    Neuronal DJ-1 regulates microglia activation via ADAM10-mediated CX3CL1 secretion

    A. Zhao, Y. Jiao, J. Liu, Y. Li (shanghai, China)

    Objective: DJ-1, also known as Parkinson's disease protein 7 (PARK7), is a multifunctional protein that is important in regulating oxidative stress and neuroprotection. Background: The…
  • 2025 International Congress

    Apolipoprotein E ɛ4-allele and Amygdala Atrophy in Parkinson’s Disease: A Preliminary Longitudinal Analysis from the ONDRI Cohort

    U. Saeed, R. Bartha, M. Binns, S. Black, D. Grimes, R. Hegele, C. Marras, . Rogaeva, M. Lang, M. Masellis (Toronto, Canada)

    Objective: To investigate the association of apolipoprotein E ɛ4-allele (APOE-ε4) with amygdala volumes longitudinally in Parkinson’s disease (PD). Background: APOE-ε4 is a genetic risk factor…
  • 2025 International Congress

    Unveiling the Molecular Mechanism of Polydatin in Ameliorating Parkinson’s Disease via the DRD2/CRYAB/NF-κB Axis in Astrocytes and Exploring Cell Therapy Strategies

    SJ. Peng, LP. Wang, YJ. Ou, RE. Liu (Beijing, China)

    Objective: Define polydatin's therapeutic mechanism targeting astrocyte-mediated neuroinflammation in Parkinson's disease (PD) and assess combinatorial efficacy with dopamine progenitor transplantation. Background: PD progression involves substantia…
  • 2025 International Congress

    Characterising Peripheral Innate Immune Cell Infiltration into the Brain in Parkinson’s Disease

    C. Tournerie, B. Patel, A. Quaegebeur, C. Williams-Gray (Cambridge, United Kingdom)

    Objective: To characterise the infiltration of peripheral innate immune cells (NK cells, monocytes and neutrophils) into the brain in Parkinson’s disease (PD) and to investigate…
  • 2025 International Congress

    Bayesian Re-Analysis of Phase I and II Subthalamic Nucleus Perfusion Changes Following Mesenchymal Stem Cell Infusion in Parkinson’s Disease

    T. Thomas, T. Ellmore, E. Tharp, J. Martinez-Lemus, C. Green, J. Suescun, C. Onuigbo, T. Le, E. Rodarte Rascon, R. Ritter Iii, M. Schiess (Houston, USA)

    Objective: To compare subthalamic nucleus (STN) perfusion changes following mesenchymal stem cell (MSC) infusion in Parkinson’s disease (PD) using Bayesian methods in both Phase I…
  • 2025 International Congress

    Ventral and Dorsal Language Pathways in Patients with Lewy Bodies: an fMRI Study of Syntactic Sentence Processing

    L. Novakova, M. Gajdos, D. Carbol, I. Rektorova (Brno, Czech Republic)

    Objective: Aim of this study is to describe specific alterations in comprehending syntactically complex sentences in patients with Lewy body diseases (LBDs) that already have…
  • 2025 International Congress

    Diffusion MRI Changes Linked to α-Synuclein Seed Amplification Status in Parkinson’s Disease

    S. Chiu, W. Wang, R. Chen, J. Desimone, C. Adler, S. Mehta, S. Dresler, N. Mcfarland, M. Okun, D. Vaillancourt (Scottsdale, USA)

    Objective: To compare free-water (FW) imaging in individuals with Parkinson’s disease (PD), with positive vs. negative cerebrospinal fluid (CSF) α-synuclein seed amplification assay (SAA) status.…
  • 2025 International Congress

    Genotypic and phenotypic characterization of the population living with Parkinson disease in the northwest region of Argentina

    C. Avila, G. Alvarado, L. Rojas-Vazquez, J. Diaz-Rearte, E. Franchello (San Miguel de Tucuman, Argentina)

    Objective: To conduct a demographic, phenotypic, and genotypic characterization of Parkinson's disease (PD) patients in northwest Argentina. Background: Despite PD's widespread nature, most genetic studies…
  • 2025 International Congress

    Deep phenotyping of Parkinson‘s disease patients with the RAB32 Ser71Arg pathogenic variant and MDSGene literature review

    T. Kleinz, F. Cavallieri, M. Borsche, G. Toschi, F. Valzania, EM. Valente, P. Mitrotti, M. Avenali, S. Zittel, R. Born, M. Matarazzo, C. Shambetova, N. Griebner, L. Santinelli, M. Brand, C. Gabbert, A. Westenberger, J. Trinh, M. Radefeldt, C. Beetz, P. Bauer, N. Brüggemann, C. Klein (Reggio Emilia, Italy)

    Objective: To evaluate patients with PD and unaffected carriers of the pathogenic variant RAB32 p.Ser71Arg using a multimodal approach to gain insight into genotype-phenotype relationships…
  • « Previous Page
  • 1
  • …
  • 138
  • 139
  • 140
  • 141
  • 142
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Welcome to the MDS Abstracts Site
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley